18 May 2021>: Database Analysis
Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
Yinqi Gao 1ABCE , Xuelong Wang 2AC , Shihui Li 1CE , Zhiqiang Zhang 1CE , Xuefei Li 1CE , Fangcai Lin 1AE*DOI: 10.12659/MSM.930025
Med Sci Monit 2021; 27:e930025
Table 2 Clinical characteristics of the patients in the training and validation cohorts.
Variables | Training cohortTCGA-TNBCN(%) | Validation CohortGSE141441N(%) | Validation CohortGSE78754N(%) |
---|---|---|---|
Normal | – | – | – |
Tumor | 114 (100%) | 130 (100%) | 63 (100%) |
(years; range) | 55 (29–84) | 57 (32–92) | 54 (30–83) |
I | 19 (16.7%) | 44 (33.8%) | – |
II | 73 (64.0%) | 72 (55.4%) | – |
III | 20 (17.5%) | 14 (10.8%) | – |
IV | 2 (1.8%) | 0 (0.0%) | – |
Metastasis | 71 (62.3%) | – | – |
Non-netastasis | 43 (37.7%) | – | – |
Alive | 100 (87.7%) | – | 20 (31.7%) |
Dead | 14 (12.3%) | – | 43 (68.3%) |
Yes | – | 68 (52.3%) | – |
No | – | 62 (47.7%) | – |